SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ — Cargene Biopharma Inc. (“Cargene”) announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capital, with participation from Hyfinity Investments, Legendstar Capital and other investors. Cargene is a preclinical-stage biopharmaceutical